National
Gingrich comes from behind to win S.C. primary
Win means three contests have gone to different candidates
Republican presidential candidate Newt Gingrich (Blade photo by Michael Key)
Republican presidential candidate Newt Gingrich pulled a surprise win in the South Carolina primary on Saturday, throwing off expectations for the race for the GOP nomination.
Media outlets projected Gingrich would win the primary immediately upon close of the polls at 7 pm. With 100 percent of precincts reporting, Gingrich captured 40.8 percent of the vote, or 243,153 of the total votes cases in the election. Former Massachusetts Gov. Mitt Romney came in a distant second with 27.8 percent.
Former U.S. Sen. Rick Santorum was in third place with 17 percent of the vote. Coming in fourth was Rep. Ron Paul (R-Texas) with 13 percent.
In victory speech in South Carolina, Gingrich said he was seeking broad support for his campaign as he took a dig at President Obama.
“We want to run not a Republican campaign; we want to run an American campaign,” Gingrich said. “This is the most important election of our lifetime. If Barack Obama can get re-elected after this disaster — right — just think of how radical he would be in a second term.”
Immediately following Gingrich’s remarks on Obama, an audience member shouted, “No more years!”
Gingrich also alluded to Romney’s campaign without mentioning the former Massachusetts governor, saying, “We don’t have the kind of money that at least one of the candidates has.” According to the latest reports, Romney has raised $32.2 million, while Gingrich has raised only $2.9 million.
“But we do have ideas, and we do have people,” Gingrich said. “And we proved here in South Carolina that people power with the right ideas beats big money, and with your help, we’re going to prove it again in Florida.”
In his speech following the results, Santorum said his campaign was about importance of families, marriage and mothers and fathers. The candidate has been vocal about his opposition to same-sex marriage.
“If we are not the party that stands up to the truth about the importance of marriage, the importance of families, the importance of fatherhood and motherhood, the importance of those values of instilling of virtues in the next generation of children with faith, then we a party that no longer has a heart, and we not a party that’s going to be a majority party in this country,” Santorum said.
Earlier this week, Romney was polling ahead of other Republicans in the Palmetto State by double-digits and observers predicted he’d win the primary. But polls on Friday began showing Gingrich was ahead, leading to the win for the candidate.
Jerame Davis, executive director of the National Stonewall Democrats, said Gingrich’s win in South Carolina demonstrates the Republican Party is reluctant to embrace Romney as their standard-bearer.
“The GOP base south of the Mason-Dixon line has never been all that fond of Mitt Romney, but the fact that South Carolina voters gave such a lopsided victory to an ethically challenged, twice divorced, serial philanderer who resigned his last position of power in disgrace is just breathtaking,” Davis said. “Republican voters are starting to see Romney for what he really is: a corporate raider who has no core values of his own and will say anything to get himself elected. The not-Romney wing of the Republican party hasn’t won yet, but they struck a major blow tonight in the Palmetto State.”
Gingrich won the primary after Texas Gov. Rick Perry dropped out of the race Thursday and threw his support behind the former U.S. House speaker. Perry was only polling in the single digits in South Carolina, but the shifted support from Perry to Gingrich likely contributed to the outcome of the contest.
Chris Barron, chief strategist for the gay conservative group GOProud, congratulated Gingrich and attributed his win to the candidate steering clear of negative attacks on Romney’s business career.
“It is clear that Speaker Gingrich’s poll numbers improved dramatically once he ended his unnecessary and unproductive attacks on Governor Mitt Romney’s record at Bain Capital,” Barron said. “As conservatives we should make it clear that we are the champions of free enterprise.”
The Gingrich win is likely troubling for Romney, who earlier this week was seen as the frontrunner for the GOP nomination. That mantle was taken from him after a recount of the Iowa caucus revealed this week that Santorum had actually won there by 34 votes.
Gingrich faces obstacles to clamping down the Republican nomination, including his admitted marital infidelities.Earlier this week, Marianne Gingrich, the candidate’s second wife, said during an ABC News interview Gingrich wanted an open relationship during the marriage. The candidate later divorced her and married his current and third wife, Callista Gingrich, with whom he was having affair while in his second marriage.
Additionally, although Gingrich has been seen as an alternative to the more moderate Romney, socially conservative, evangelical leaders threw their support behind Santorum during a meeting in Texas last week.
The thrice-married Gingrich is an opponent of same-sex marriage and signed a pledge from the anti-gay National Organization for Marriage committing himself upon election as president to backing a Federal Marriage Amendment, defending the Defense of Marriage Act in court and establishing a presidential commission on “religious liberty.”
Brian Brown, NOM’s president, congratulated Gingrich for his victory and noted each of the winners so far in the Republican presidential primaries adhere to the organization’s opposition to same-sex marriage. Paul hasn’t signed NOM’s pledge.
“NOM congratulates Newt Gingrich on his impressive come-from-behind victory in South Carolina,” Brown said. “We have had three different victors in state contests thus far — Rick Santorum in Iowa, Mitt Romney in New Hampshire and now Newt Gingrich in South Carolina. What all these states have in common is that they have picked candidates who have signed NOM’s Marriage Pledge They are all winners and NOM supports each of them.”
Romney also continues to lead in the national polls. A Gallup poll published Friday gave him a 10-point lead over Gingrich. However, the lead Romney enjoys has been diminished from the standing he enjoyed earlier this week, when he had a 23-point lead over both Gingrich and Santorum.
R. Clarke Cooper, executive director of the National Log Cabin Republicans, said the Florida Republican primary — set to take place Jan. 31 — will be a “greater mark” of who Republicans want to rally around as their nominee.
“Like all Republicans during primary season, Log Cabin Republicans, including our members in the Palmetto state, have differing views of who should be our nominee,” Cooper said “Unlike South Carolina, the demographics of Florida provide an electorate closer to what the nominee will face in the November general election.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
Comings & Goings
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
Why queer spaces often fail South Asian women
